550378-07-9 Usage
General Description
(R)-2-(aminoethyl)-1-N-BOC-pyrrolidine is a chemical compound that belongs to the class of organic compounds known as communes. It is a synthetic intermediate that is used in the pharmaceutical industry for the production of various drugs. The compound has a pyrrolidine ring with an aminoethyl moiety and a BOC protecting group, which makes it useful for different chemical reactions and transformations. It has applications in the synthesis of various pharmaceuticals and can be used as a building block for the production of other complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 550378-07-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,0,3,7 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 550378-07:
(8*5)+(7*5)+(6*0)+(5*3)+(4*7)+(3*8)+(2*0)+(1*7)=149
149 % 10 = 9
So 550378-07-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H22N2O2/c1-11(2,3)15-10(14)13-8-4-5-9(13)6-7-12/h9H,4-8,12H2,1-3H3/t9-/m1/s1
550378-07-9Relevant articles and documents
Sulfonamides having antiangiogenic and anticancer activity
-
, (2008/06/13)
Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.
INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2
-
Page 42-43, (2008/06/13)
Pharmaceutical compositions containing organic compounds or salts thereof that serve as modulators for the SDF-1 or I-TAC chemokines are disclosed. The compounds and compositions are useful in the treatment of cancer, especially in the inhibition of cancer proliferation, growth, and metastasis. Methods of interfering with SDF-1 and/or I-TAC binding to the CCXCKR2 receptor and treating cancer using the compounds and pharmaceutical compositions of the present invention are also disclosed.